Creating new antiviral drugs: Katherine Seley-Radtke’s innovative “fleximer” research to receive $3.5M from NIH

dc.contributor	Demond, Marlayna
dc.contributor.author	Hansen, Sarah
dc.date.accessioned	2024-03-11T16:08:06Z
dc.date.available	2024-03-11T16:08:06Z
dc.date.issued	2022-06-10
dc.description	Photographer: Marlayna Demond
dc.description.uri	https://umbc.edu/stories/antiviral-research-receives-3-5m-from-nih/
dc.format.extent	9 pages
dc.genre	articles
dc.identifier	doi:10.13016/m2l99a-ptzl
dc.identifier.citation	Hansen, Sarah. “Creating New Antiviral Drugs: Katherine Seley-Radtke’s Innovative ‘Fleximer’ Research To Receive $3.5M From NIH,” UMBC News. Science & Tech. June 10, 2022. https://umbc.edu/stories/antiviral-research-receives-3-5m-from-nih/.
dc.identifier.uri	http://hdl.handle.net/11603/31921
dc.language.iso	en_US
dc.publisher	UMBC News
dc.relation.isAvailableAt	The University of Maryland, Baltimore County (UMBC)
dc.relation.ispartof	About UMBC and Its People Collection
dc.relation.ispartof	UMBC Staff Collection
dc.relation.ispartof	UMBC Chemistry & Biochemistry Department
dc.rights	This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subject	Katherine Seley-Radtke
dc.subject	UMBC Chemistry & Biochemistry Department
dc.title	Creating new antiviral drugs: Katherine Seley-Radtke’s innovative “fleximer” research to receive $3.5M from NIH
dc.type	Text

Files

Now showing 1 - 1 of 1

Name:: Creating New Antiviral Drugs_ Katherine Seley-Radtke’s Innovative “fleximer” Research To Receive $3.5M From NIH - UMBC_ University Of Maryland, Baltimore County.pdf
Size:: 1.91 MB
Format:: Adobe Portable Document Format

Now showing 1 - 1 of 1